AstraZeneca PLC Recruits "Saudi Overseas Direction" Partners
Supplier Advantages: This article introduces the recruitment needs of AstraZeneca's Saudi Arabia project, seeking partners in fields such as mRNA vaccines, cell and stem cell therapies, clinical trials for oncology and infectious diseases, and the application of AI in clinical trials and medical data. Outstanding projects will have the opportunity to join AstraZeneca’s Saudi ecosystem and participate in exchange activities during the Saudi delegation's visit to China in early 2024, aiming to promote in-depth cooperation and explore potential investment opportunities.
| Published by | AstraZeneca | Department | -- |
|---|---|---|---|
| Region | England,United Kingdom | Budget | -- |
| Validity | Long-term | ||
1. Recruitment Needs
Potential partners in the following fields with intentions to expand to Saudi Arabia
Demand 1: mRNA Vaccine Related Enterprises
Demand Two: Enterprises Related to Cell and Stem Cell Therapy
Demand Three: Companies providing clinical trials (especially Phase 1 and Phase 2) and real-world evidence studies related to oncology and infectious diseases.
Demand Four: AI-related Enterprises Applied in Clinical Trial Stage
Demand Five: AI-related enterprises in medical data applied to the clinical research stage
2. Project Cooperation Direction
Outstanding projects will have the opportunity to join AstraZeneca's Saudi ecosystem, participate in the Saudi delegation's visit to China in early 2024, engage in in-depth exchanges with the Saudi delegation, gain potential investment cooperation opportunities, and conduct in-depth discussions on future collaboration directions.